A company that sells a generic version of a drug made by Procter & Gamble Co. lost its appeal to prevent the consumer products maker from marketing a separate form of the medication through a licensee.
A company that sells a generic version of a drug made by Procter & Gamble Co. lost its appeal to prevent the consumer products maker from marketing a separate form of the medication through a licensee.
